Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
melanoma
|
0.583 | 0.600 | 1 | 114713908 | missense variant | T/A;C;G | snv | 0.800 | 1.000 | 16 | 1989 | 2019 | |||||||
GIANT PIGMENTED HAIRY NEVUS
|
0.583 | 0.600 | 1 | 114713908 | missense variant | T/A;C;G | snv | 0.800 | 0 | ||||||||||
Neurocutaneous melanosis
|
0.583 | 0.600 | 1 | 114713908 | missense variant | T/A;C;G | snv | 0.800 | 0 | ||||||||||
NEVUS, EPIDERMAL (disorder)
|
0.583 | 0.600 | 1 | 114713908 | missense variant | T/A;C;G | snv | 0.800 | 0 | ||||||||||
THYROID CANCER, NONMEDULLARY, 2
|
0.583 | 0.600 | 1 | 114713908 | missense variant | T/A;C;G | snv | 0.800 | 0 | ||||||||||
Thyroid Neoplasm
|
0.583 | 0.600 | 1 | 114713908 | missense variant | T/A;C;G | snv | 0.720 | 1.000 | 1 | 2016 | 2017 | |||||||
Leukemia, Myelocytic, Acute
|
0.583 | 0.600 | 1 | 114713908 | missense variant | T/A;C;G | snv | 0.710 | 1.000 | 6 | 1987 | 2016 | |||||||
Chronic Lymphocytic Leukemia
|
0.583 | 0.600 | 1 | 114713908 | missense variant | T/A;C;G | snv | 0.710 | 1.000 | 1 | 1997 | 2016 | |||||||
Non-Small Cell Lung Carcinoma
|
0.583 | 0.600 | 1 | 114713908 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 9 | 1984 | 2014 | |||||||
Colorectal Neoplasms
|
0.583 | 0.600 | 1 | 114713908 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 8 | 2006 | 2016 | |||||||
Adenocarcinoma of lung (disorder)
|
0.583 | 0.600 | 1 | 114713908 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
Adrenocortical carcinoma
|
0.583 | 0.600 | 1 | 114713908 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
Brain Neoplasms
|
0.583 | 0.600 | 1 | 114713908 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
Cutaneous Melanoma
|
0.583 | 0.600 | 1 | 114713908 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
Gastric Adenocarcinoma
|
0.583 | 0.600 | 1 | 114713908 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
Glioblastoma
|
0.583 | 0.600 | 1 | 114713908 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
Liver carcinoma
|
0.583 | 0.600 | 1 | 114713908 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
Malignant Uterine Corpus Neoplasm
|
0.583 | 0.600 | 1 | 114713908 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
Multiple Myeloma
|
0.583 | 0.600 | 1 | 114713908 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
Nasopharyngeal Neoplasms
|
0.583 | 0.600 | 1 | 114713908 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
Renal Cell Carcinoma
|
0.583 | 0.600 | 1 | 114713908 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
Serous cystadenocarcinoma ovary
|
0.583 | 0.600 | 1 | 114713908 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
Transitional cell carcinoma of bladder
|
0.583 | 0.600 | 1 | 114713908 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
Nevus Sebaceus of Jadassohn
|
0.583 | 0.600 | 1 | 114713908 | missense variant | T/A;C;G | snv | 0.700 | 0 | ||||||||||
Organoid Nevus Phakomatosis
|
0.583 | 0.600 | 1 | 114713908 | missense variant | T/A;C;G | snv | 0.700 | 0 |